The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
- DOI
- 10.1186/s40425-016-0188-z
- Published
- 2016
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40425-016-0188-z,
title = {The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.},
author = {Boyiadzis M and Bishop MR and Abonour R and Anderson KC and Ansell SM and Avigan D and Barbarotta L and Barrett AJ and Van Besien K and Bergsagel PL and Borrello I and Brody J and Brufsky J and Cairo M and Chari A and Cohen A and Cortes J and Forman SJ and Friedberg JW and Fuchs EJ and Gore SD and Jagannath S and Kahl BS and Kline J and Kochenderfer JN and Kwak LW and Levy R and de Lima M and Litzow MR and Mahindra A and Miller J and Munshi NC and Orlowski RZ and Pagel JM and Porter DL and Russell SJ and Schwartz K and Shipp MA and Siegel D and Stone RM and Tallman MS and Timmerman JM and Van Rhee F and Waller EK and Welsh A and Werner M and Wiernik PH and Dhodapkar MV},
year = {2016},
journal = {Journal for immunotherapy of cancer},
doi = {10.1186/s40425-016-0188-z},
url = {https://doi.org/10.1186/s40425-016-0188-z}
}RIS
TY - JOUR TI - The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia. AU - Boyiadzis M AU - Bishop MR AU - Abonour R AU - Anderson KC AU - Ansell SM AU - Avigan D AU - Barbarotta L AU - Barrett AJ AU - Van Besien K AU - Bergsagel PL AU - Borrello I AU - Brody J AU - Brufsky J AU - Cairo M AU - Chari A AU - Cohen A AU - Cortes J AU - Forman SJ AU - Friedberg JW AU - Fuchs EJ AU - Gore SD AU - Jagannath S AU - Kahl BS AU - Kline J AU - Kochenderfer JN AU - Kwak LW AU - Levy R AU - de Lima M AU - Litzow MR AU - Mahindra A AU - Miller J AU - Munshi NC AU - Orlowski RZ AU - Pagel JM AU - Porter DL AU - Russell SJ AU - Schwartz K AU - Shipp MA AU - Siegel D AU - Stone RM AU - Tallman MS AU - Timmerman JM AU - Van Rhee F AU - Waller EK AU - Welsh A AU - Werner M AU - Wiernik PH AU - Dhodapkar MV PY - 2016 JO - Journal for immunotherapy of cancer DO - 10.1186/s40425-016-0188-z UR - https://doi.org/10.1186/s40425-016-0188-z ER -
APA
M, B., MR, B., R, A., KC, A., SM, A., D, A., L, B., AJ, B., K, V. B., PL, B., I, B., J, B., J, B., M, C., A, C., A, C., J, C., SJ, F., JW, F., EJ, F., SD, G., S, J., BS, K., J, K., JN, K., LW, K., R, L., M, D. L., MR, L., A, M., J, M., NC, M., RZ, O., JM, P., DL, P., SJ, R., K, S., MA, S., D, S., RM, S., MS, T., JM, T., F, V. R., EK, W., A, W., M, W., PH, W., & MV, D. (2016). The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.. Journal for immunotherapy of cancer. https://doi.org/10.1186/s40425-016-0188-z
Source records
- pubmed · retrieved 2026-09-26T05:11:25.225Z
- europe-pmc · retrieved 2026-09-26T05:11:25.238Z
- doaj · retrieved 2026-09-26T05:11:25.226Z